Brief: Laurus Labs Says US FDA Issued One Observation For Foreign Subsidiary Of Co
22/01/2025 12:40
Jan 22 (Reuters) - Laurus Labs Ltd LAUL.NS :
* US FDA ISSUED ONE OBSERVATION FOR FOREIGN SUBSIDIARY OF
LAURUS
LABS
* OBSERVATION ISSUED AFTER POST-MARKETING ADVERSE DRUG
EXPERIENCE
INSPECTION BY US FDA
Source text: ID:nBSEb7YxX3
Further company coverage: LAUL.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig